BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 30176705)

  • 1. Aberrant Tendency of Noncurrent Emotional Experiences in Individuals at Ultra-High Risk for Psychosis.
    Seo E; Bang M; Lee E; An SK
    Psychiatry Investig; 2018 Sep; 15(9):876-883. PubMed ID: 30176705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experiential pleasure deficits in the prodrome: A study of emotional experiences in individuals at ultra-high risk for psychosis and recent-onset schizophrenia.
    Jhung K; Park JY; Song YY; Kang JI; Lee E; An SK
    Compr Psychiatry; 2016 Jul; 68():209-16. PubMed ID: 27234204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors Associated With Psychosocial Functioning and Outcome of Individuals With Recent-Onset Schizophrenia and at Ultra-High Risk for Psychosis.
    Kim HK; Park HY; Seo E; Bang M; Song YY; Lee SY; Kim KR; Park JY; Kang JI; Lee E; An SK
    Front Psychiatry; 2019; 10():459. PubMed ID: 31293463
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuroleptic-free youth at ultrahigh risk for psychosis evidence diminished emotion reactivity that is predicted by depression and anxiety.
    Gruber J; Strauss GP; Dombrecht L; Mittal VA
    Schizophr Res; 2018 Mar; 193():428-434. PubMed ID: 28811079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anhedonia in adolescents at ultra-high risk (UHR) of psychosis: findings from a 1-year longitudinal study.
    Pelizza L; Poletti M; Azzali S; Paterlini F; Garlassi S; Scazza I; Chiri LR; Pupo S; Gebhardt E; Raballo A
    Eur Arch Psychiatry Clin Neurosci; 2020 Apr; 270(3):337-350. PubMed ID: 31055617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired facial emotion recognition in individuals at ultra-high risk for psychosis and with first-episode schizophrenia, and their associations with neurocognitive deficits and self-reported schizotypy.
    Lee SY; Bang M; Kim KR; Lee MK; Park JY; Song YY; Kang JI; Lee E; An SK
    Schizophr Res; 2015 Jun; 165(1):60-5. PubMed ID: 25864951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fragile Self and Malevolent Others: Biased Attribution Styles in Individuals at Ultra-High Risk for Psychosis.
    Park HY; Bang M; Kim KR; Lee E; An SK
    Psychiatry Investig; 2018 Aug; 15(8):796-804. PubMed ID: 30134645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anhedonia in the Psychosis Risk Syndrome: State and Trait Characteristics.
    Pelizza L; Azzali S; Paterlini F; Garlassi S; Scazza I; Chiri LR; Poletti M; Pupo S; Raballo A
    Psychiatr Danub; 2021; 33(1):36-47. PubMed ID: 33857038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diminished Hedonic response in neuroleptic-free youth at ultra high-risk for psychosis.
    Strauss GP; Ruiz I; Visser KH; Crespo LP; Dickinson EK
    Schizophr Res Cogn; 2018 Jun; 12():1-7. PubMed ID: 29928593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emotional Experience of People With Schizophrenia and People at Risk for Psychosis: A Meta-Analysis.
    Riehle M; Straková A; Lincoln TM
    JAMA Psychiatry; 2024 Jan; 81(1):57-66. PubMed ID: 37755868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychotic conversion of individuals at ultra-high risk for psychosis: The potential roles of schizotypy and basic symptoms.
    Bang M; Park JY; Kim KR; Lee SY; Song YY; Kang JI; Lee E; An SK
    Early Interv Psychiatry; 2019 Jun; 13(3):546-554. PubMed ID: 29218852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between psychosocial functioning and resilience and negative symptoms in individuals at ultra-high risk for psychosis.
    Kim KR; Song YY; Park JY; Lee EH; Lee M; Lee SY; Kang JI; Lee E; Yoo SW; An SK; Kwon JS
    Aust N Z J Psychiatry; 2013 Aug; 47(8):762-71. PubMed ID: 23661784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired Facial Emotion Recognition in Individuals at Ultra-High Risk for Psychosis and Associations With Schizotypy and Paranoia Level.
    Seo E; Park HY; Park K; Koo SJ; Lee SY; Min JE; Lee E; An SK
    Front Psychiatry; 2020; 11():577. PubMed ID: 32676040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired Social and Role Function in Ultra-High Risk for Psychosis and First-Episode Schizophrenia: Its Relations with Negative Symptoms.
    Lee SJ; Kim KR; Lee SY; An SK
    Psychiatry Investig; 2017 Mar; 14(2):186-192. PubMed ID: 28326117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired Social and Role Function in Ultra-High Risk for Psychosis and First-Episode Schizophrenia: Its Relations with Negative Symptoms.
    Lee SJ; Kim KR; Lee SY; An SK
    Psychiatry Investig; 2017 Sep; 14(5):539-545. PubMed ID: 29042877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emotion recognition latency, but not accuracy, relates to real life functioning in individuals at ultra-high risk for psychosis.
    Glenthøj LB; Albert N; Fagerlund B; Kristensen TD; Wenneberg C; Hjorthøj C; Nordentoft M; Jepsen JRM
    Schizophr Res; 2019 Aug; 210():197-202. PubMed ID: 30595441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Ultra-High-Risk for psychosis groups: Evidence to maintain the status quo.
    McHugh MJ; McGorry PD; Yuen HP; Hickie IB; Thompson A; de Haan L; Mossaheb N; Smesny S; Lin A; Markulev C; Schloegelhofer M; Wood SJ; Nieman D; Hartmann JA; Nordentoft M; Schäfer M; Amminger GP; Yung A; Nelson B
    Schizophr Res; 2018 May; 195():543-548. PubMed ID: 29055567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new perspective on anhedonia in schizophrenia.
    Strauss GP; Gold JM
    Am J Psychiatry; 2012 Apr; 169(4):364-73. PubMed ID: 22407079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perceived stress mediates the relationship between social adaptation and quality of life in individuals at ultra high risk of psychosis.
    Ortega L; Montalvo I; Monseny R; Vilella E; Labad J
    Early Interv Psychiatry; 2019 Dec; 13(6):1447-1454. PubMed ID: 30690915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurocognition as a predictor of transition to psychotic disorder and functional outcomes in ultra-high risk participants: Findings from the NEURAPRO randomized clinical trial.
    Bolt LK; Amminger GP; Farhall J; McGorry PD; Nelson B; Markulev C; Yuen HP; Schäfer MR; Mossaheb N; Schlögelhofer M; Smesny S; Hickie IB; Berger GE; Chen EYH; de Haan L; Nieman DH; Nordentoft M; Riecher-Rössler A; Verma S; Thompson A; Yung AR; Allott KA
    Schizophr Res; 2019 Apr; 206():67-74. PubMed ID: 30558978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.